OncoCyte Corp (OCX)
2.94
+0.02
(+0.68%)
USD |
NASDAQ |
Jun 28, 16:00
2.93
-0.01
(-0.34%)
After-Hours: 20:00
OncoCyte Gross Profit (Quarterly): -0.098M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.098M |
| December 31, 2023 | -0.117M |
| September 30, 2023 | 0.248M |
| June 30, 2023 | 0.272M |
| March 31, 2023 | 0.01M |
| December 31, 2022 | -0.027M |
| September 30, 2022 | -0.269M |
| June 30, 2022 | 0.031M |
| March 31, 2022 | 0.247M |
| December 31, 2021 | 2.601M |
| Date | Value |
|---|---|
| September 30, 2021 | -0.866M |
| June 30, 2021 | -0.394M |
| March 31, 2021 | 0.079M |
| December 31, 2020 | -0.213M |
| September 30, 2020 | -0.046M |
| June 30, 2020 | -0.222M |
| March 31, 2020 | -0.157M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
-0.866M
Minimum
Sep 2021
2.601M
Maximum
Dec 2021
0.0539M
Average
-0.0135M
Median
Gross Profit (Quarterly) Benchmarks
| Fonar Corp | 11.75M |
| XWELL Inc | 2.671M |
| ProPhase Labs Inc | -0.433M |
| Applied DNA Sciences Inc | 0.2957M |
| Veracyte Inc | 65.38M |